1 77350sek
0,5 %
Date:2026-01-15Time:09:26:14Latest report:Q3-2025List:Large CapTicker:AZN
Market Cap:2 743 556 msekEnterprise Value:2 969 218 msekNet Sales:58 127 musdEarnings:9 399 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 765,00
MA50:1 688,89
MA200:1 493,73
Price/MA200:18,2 %
RSI (14):64,1
Price/MA50:4,5 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals